zandelisib
mei,kyowa kirin
['zandelisib', 'lymsm', 'tidal']
jurczak - tidal (zandelisib in r/r fl)
- cont dosing 2 cycles then 1wk on, 3 off
- &lt; 10% discon due to ae
- 8% g3+ diarrhoea
- orr 70%, crr 35%
- short fu, no dor shown
impressive data. pi3k inhibition not yet dead! #eha2022 #eha22 #lymsm 
Lymphoma specialist at Oxford Cancer and Haematology centre. Haematologist and clinical trialist. Past chair of UK Hodgkin and T-cell study groups.